StemCells, Inc. Initiates Phase II Clinical Trial in Cervical Spinal Cord Injury

Posted byclientekdevPosted instem cell research

http://www.marketwatch.com/story/stemcells-inc-initiates-phase-ii-clinical-trial-in-cervical-spinal-cord-injury-2014-10-07

StemCells, Inc. STEM, -3.17% a world leader in the research and development of cell based therapies for the treatment of disorders of the central nervous system, announced today that it has initiated its Pathway® Study, a Phase II proof of concept clinical trial using its proprietary HuCNS-SC® platform of human neural stem cells for the treatment of cervical spinal cord injury (SCI).